Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV

Use of antiretrovirals is widespread in Brazil, where more than 200,000 individuals are under treatment. Although general prevalence of primary antiretroviral resistance in Brazil is low, systematic sampling in large metropolitan areas has not being performed. The HIV Threshold Survey methodology (H...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the International AIDS Society Vol. 12; no. 1; p. 20
Main Authors: Inocencio, Lilian A, Pereira, Anderson A, Sucupira, Maria Cecilia A, Fernandez, José Carlos C, Jorge, Célia P, Souza, Denise FC, Fink, Helena T, Diaz, Ricardo S, Becker, Irina M, Suffert, Theodoro A, Arruda, Monica B, Macedo, Olinda, Simão, Mariangela BG, Tanuri, Amilcar
Format: Journal Article
Language:English
Published: Switzerland The International AIDS Society 18-09-2009
John Wiley & Sons, Inc
BioMed Central Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Use of antiretrovirals is widespread in Brazil, where more than 200,000 individuals are under treatment. Although general prevalence of primary antiretroviral resistance in Brazil is low, systematic sampling in large metropolitan areas has not being performed. The HIV Threshold Survey methodology (HIV‐THS, WHO) was utilized, targeting Brazil's four major regions and selecting the six most populated state capitals: Sao Paulo, Rio de Janeiro, Salvador, Porto Alegre, Brasilia and Belem. We were able to sequence samples from 210 individuals with recent HIV diagnosis, 17 of them (8.1%) carrying HIV isolates with primary antiretroviral resistance mutations. Five, nine and four isolates showed mutations related to resistance to nucleoside reverse transcriptase inhibitors (NRTIs), non‐nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs), respectively. Using HIV‐THS, we could find an intermediate level of transmitted resistance (5% to 15%) in Belem/Brasilia, Sao Paulo and Rio de Janeiro. Lower level of transmitted resistance (<5%) were observed in the other areas. Despite the extensive antiretroviral exposure and high rates of virologic antiretroviral failure in Brazil, the general prevalence of primary resistance is still low. However, an intermediate level of primary resistance was found in the four major Brazilian cities, confirming the critical need to start larger sampling surveys to better define the risk factors associated with transmission of resistant HIV.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1758-2652
1758-2652
DOI:10.1186/1758-2652-12-20